NCT02311049View on ClinicalTrials.gov

Hypofractionated Radiotherapy for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

June 14, 2020

Study Completion Date

June 14, 2020

Conditions
Prostate Cancer
Interventions
RADIATION

Hypofractionation

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02311049 - Hypofractionated Radiotherapy for Prostate Cancer | Biotech Hunter | Biotech Hunter